Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant DNA (rDNA) Technology market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant DNA (rDNA) Technology industry.
Based on our recent survey, we have several different scenarios about the Recombinant DNA (rDNA) Technology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant DNA (rDNA) Technology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA (rDNA) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA (rDNA) Technology market in terms of revenue.
Players, stakeholders, and other participants in the global Recombinant DNA (rDNA) Technology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each component segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant DNA (rDNA) Technology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant DNA (rDNA) Technology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA (rDNA) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA (rDNA) Technology market.
The following players are covered in this report:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Recombinant DNA (rDNA) Technology Breakdown Data by Component
Expression System
Cloning Vector
Recombinant DNA (rDNA) Technology Breakdown Data by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant DNA (rDNA) Technology industry.
Based on our recent survey, we have several different scenarios about the Recombinant DNA (rDNA) Technology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant DNA (rDNA) Technology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA (rDNA) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA (rDNA) Technology market in terms of revenue.
Players, stakeholders, and other participants in the global Recombinant DNA (rDNA) Technology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each component segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant DNA (rDNA) Technology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant DNA (rDNA) Technology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA (rDNA) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA (rDNA) Technology market.
The following players are covered in this report:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Recombinant DNA (rDNA) Technology Breakdown Data by Component
Expression System
Cloning Vector
Recombinant DNA (rDNA) Technology Breakdown Data by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
1.4 Covid-19 Implications on Market by Component
1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026
1.4.2 Expression System
1.4.3 Cloning Vector
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Academic and Government Research Institutes
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry
1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions
2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019
3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Component (2015-2026)
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020)
7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
8 China
8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020)
8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020)
8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020)
9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020)
9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020)
10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
11 India
11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020)
11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020)
11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
13Key Players Profiles
13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
13.2 Profacgen
13.2.1 Profacgen Company Details
13.2.2 Profacgen Business Overview and Its Total Revenue
13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.2.5 Profacgen Recent Development
13.3 Amgen Inc
13.3.1 Amgen Inc Company Details
13.3.2 Amgen Inc Business Overview and Its Total Revenue
13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.3.5 Amgen Inc Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 GenScript
13.5.1 GenScript Company Details
13.5.2 GenScript Business Overview and Its Total Revenue
13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.5.5 GenScript Recent Development
13.6 Pfizer Inc
13.6.1 Pfizer Inc Company Details
13.6.2 Pfizer Inc Business Overview and Its Total Revenue
13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.6.5 Pfizer Inc Recent Development
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S Company Details
13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.7.5 Novo Nordisk A/S Recent Development
13.8 Eli Lilly and Company
13.8.1 Eli Lilly and Company Company Details
13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.8.5 Eli Lilly and Company Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 Biocon
13.10.1 Biocon Company Details
13.10.2 Biocon Business Overview and Its Total Revenue
13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.10.5 Biocon Recent Development
13.11 GlaxoSmithKline plc
10.11.1 GlaxoSmithKline plc Company Details
10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.11.5 GlaxoSmithKline plc Recent Development
13.12 New England Biolabs.
10.12.1 New England Biolabs. Company Details
10.12.2 New England Biolabs. Business Overview and Its Total Revenue
10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.12.5 New England Biolabs. Recent Development
13.13 Cibus
10.13.1 Cibus Company Details
10.13.2 Cibus Business Overview and Its Total Revenue
10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.13.5 Cibus Recent Development
13.14 Monsanto Company
10.14.1 Monsanto Company Company Details
10.14.2 Monsanto Company Business Overview and Its Total Revenue
10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.14.5 Monsanto Company Recent Development
13.15 Horizon Discovery Group PLC
10.15.1 Horizon Discovery Group PLC Company Details
10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.15.5 Horizon Discovery Group PLC Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
1.4 Covid-19 Implications on Market by Component
1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026
1.4.2 Expression System
1.4.3 Cloning Vector
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Academic and Government Research Institutes
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry
1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions
2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019
3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Component (2015-2026)
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020)
7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
8 China
8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020)
8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020)
8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020)
9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020)
9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020)
10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
11 India
11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020)
11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020)
11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
13Key Players Profiles
13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
13.2 Profacgen
13.2.1 Profacgen Company Details
13.2.2 Profacgen Business Overview and Its Total Revenue
13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.2.5 Profacgen Recent Development
13.3 Amgen Inc
13.3.1 Amgen Inc Company Details
13.3.2 Amgen Inc Business Overview and Its Total Revenue
13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.3.5 Amgen Inc Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 GenScript
13.5.1 GenScript Company Details
13.5.2 GenScript Business Overview and Its Total Revenue
13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.5.5 GenScript Recent Development
13.6 Pfizer Inc
13.6.1 Pfizer Inc Company Details
13.6.2 Pfizer Inc Business Overview and Its Total Revenue
13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.6.5 Pfizer Inc Recent Development
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S Company Details
13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.7.5 Novo Nordisk A/S Recent Development
13.8 Eli Lilly and Company
13.8.1 Eli Lilly and Company Company Details
13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.8.5 Eli Lilly and Company Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 Biocon
13.10.1 Biocon Company Details
13.10.2 Biocon Business Overview and Its Total Revenue
13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.10.5 Biocon Recent Development
13.11 GlaxoSmithKline plc
10.11.1 GlaxoSmithKline plc Company Details
10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.11.5 GlaxoSmithKline plc Recent Development
13.12 New England Biolabs.
10.12.1 New England Biolabs. Company Details
10.12.2 New England Biolabs. Business Overview and Its Total Revenue
10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.12.5 New England Biolabs. Recent Development
13.13 Cibus
10.13.1 Cibus Company Details
10.13.2 Cibus Business Overview and Its Total Revenue
10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.13.5 Cibus Recent Development
13.14 Monsanto Company
10.14.1 Monsanto Company Company Details
10.14.2 Monsanto Company Business Overview and Its Total Revenue
10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.14.5 Monsanto Company Recent Development
13.15 Horizon Discovery Group PLC
10.15.1 Horizon Discovery Group PLC Company Details
10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.15.5 Horizon Discovery Group PLC Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
